• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A vaccine antigen central in influenza A(H5) virus antigenic space confers subtype-wide immunity.甲型流感病毒A(H5)抗原空间中的一种疫苗抗原可提供亚型广泛的免疫力。
bioRxiv. 2024 Aug 6:2024.08.06.606696. doi: 10.1101/2024.08.06.606696.
2
Recombinant parainfluenza virus 5 expressing clade 2.3.4.4b H5 hemagglutinin protein confers broad protection against H5Ny influenza viruses.表达 2.3.4.4b 分支 H5 血凝素蛋白的重组副流感病毒 5 可提供针对 H5Ny 流感病毒的广泛保护。
J Virol. 2024 Mar 19;98(3):e0112923. doi: 10.1128/jvi.01129-23. Epub 2024 Feb 2.
3
Cross-Protection by Inactivated H5 Prepandemic Vaccine Seed Strains against Diverse Goose/Guangdong Lineage H5N1 Highly Pathogenic Avian Influenza Viruses.灭活 H5 疫苗种株对不同鸭/广东谱系 H5N1 高致病性禽流感病毒的交叉保护作用。
J Virol. 2020 Nov 23;94(24). doi: 10.1128/JVI.00720-20.
4
Broadly Reactive IgG Responses to Heterologous H5 Prime-Boost Influenza Vaccination Are Shaped by Antigenic Relatedness to Priming Strains.广泛反应性 IgG 对异源 H5 疫苗加强免疫的反应受与初始株抗原相关性的影响。
mBio. 2021 Aug 31;12(4):e0044921. doi: 10.1128/mBio.00449-21. Epub 2021 Jul 6.
5
Efficacy of recombinant Marek's disease virus vectored vaccines with computationally optimized broadly reactive antigen (COBRA) hemagglutinin insert against genetically diverse H5 high pathogenicity avian influenza viruses.计算优化的广泛反应性抗原(COBRA)血凝素插入的重组马立克氏病病毒载体疫苗对遗传多样的 H5 高致病性禽流感病毒的效力。
Vaccine. 2021 Apr 1;39(14):1933-1942. doi: 10.1016/j.vaccine.2021.02.075. Epub 2021 Mar 11.
6
Development of Clade-Specific and Broadly Reactive Live Attenuated Influenza Virus Vaccines against Rapidly Evolving H5 Subtype Viruses.针对快速进化的H5亚型病毒开发具有分支特异性和广泛反应性的减毒活流感病毒疫苗。
J Virol. 2017 Jul 12;91(15). doi: 10.1128/JVI.00547-17. Print 2017 Aug 1.
7
A computationally designed H5 antigen shows immunological breadth of coverage and protects against drifting avian strains.一种经过计算设计的 H5 抗原表现出广泛的免疫覆盖范围,并能预防漂移的禽流感株。
Vaccine. 2019 Apr 17;37(17):2369-2376. doi: 10.1016/j.vaccine.2019.03.018. Epub 2019 Mar 21.
8
Stockpiled pre-pandemic H5N1 influenza virus vaccines with AS03 adjuvant provide cross-protection from H5N2 clade 2.3.4.4 virus challenge in ferrets.储备的大流行前含AS03佐剂的H5N1流感病毒疫苗可在雪貂中对H5N2 2.3.4.4分支病毒攻击提供交叉保护。
Virology. 2017 Aug;508:164-169. doi: 10.1016/j.virol.2017.05.010. Epub 2017 May 26.
9
Development of a nucleoside-modified mRNA vaccine against clade 2.3.4.4b H5 highly pathogenic avian influenza virus.针对 2.3.4.4b 谱系 H5 高致病性禽流感病毒的核苷修饰 mRNA 疫苗的研制。
Nat Commun. 2024 May 23;15(1):4350. doi: 10.1038/s41467-024-48555-z.
10
Prime-Boost Vaccination With a Novel Hemagglutinin Protein Produced in Bacteria Induces Neutralizing Antibody Responses Against H5-Subtype Influenza Viruses in Commercial Chickens.用细菌生产的新型血凝素蛋白进行 Prime-Boost 疫苗接种可诱导商业肉鸡产生针对 H5 亚型流感病毒的中和抗体反应。
Front Immunol. 2019 Sep 4;10:2006. doi: 10.3389/fimmu.2019.02006. eCollection 2019.

本文引用的文献

1
Detection and spread of high pathogenicity avian influenza virus H5N1 in the Antarctic Region.南极地区高致病性禽流感病毒 H5N1 的检测与传播。
Nat Commun. 2024 Sep 3;15(1):7433. doi: 10.1038/s41467-024-51490-8.
2
Australia's first human case of H5N1 and the current H7 poultry outbreaks: implications for public health and biosecurity measures.澳大利亚首例H5N1人类病例及当前H7家禽疫情:对公共卫生和生物安全措施的影响。
Lancet Reg Health West Pac. 2024 Jul 19;48:101141. doi: 10.1016/j.lanwpc.2024.101141. eCollection 2024 Jul.
3
Spillover of highly pathogenic avian influenza H5N1 virus to dairy cattle.
高致病性禽流感 H5N1 病毒向奶牛的溢出。
Nature. 2024 Oct;634(8034):669-676. doi: 10.1038/s41586-024-07849-4. Epub 2024 Jul 25.
4
H19 influenza A virus exhibits species-specific MHC class II receptor usage.H19 流感 A 病毒表现出物种特异性 MHC Ⅱ类受体利用。
Cell Host Microbe. 2024 Jul 10;32(7):1089-1102.e10. doi: 10.1016/j.chom.2024.05.018. Epub 2024 Jun 17.
5
Development of a nucleoside-modified mRNA vaccine against clade 2.3.4.4b H5 highly pathogenic avian influenza virus.针对 2.3.4.4b 谱系 H5 高致病性禽流感病毒的核苷修饰 mRNA 疫苗的研制。
Nat Commun. 2024 May 23;15(1):4350. doi: 10.1038/s41467-024-48555-z.
6
Avian Influenza A(H5N1) Neuraminidase Inhibition Antibodies in Healthy Adults after Exposure to Influenza A(H1N1)pdm09.健康成年人接触甲型流感(H1N1)pdm09 后对甲型流感 A(H5N1)神经氨酸酶的抑制抗体
Emerg Infect Dis. 2024 Jan;30(1):168-171. doi: 10.3201/eid3001.230756.
7
Mass Mortality of Sea Lions Caused by Highly Pathogenic Avian Influenza A(H5N1) Virus.海狮大规模死亡是由高致病性禽流感病毒(H5N1)引起的。
Emerg Infect Dis. 2023 Dec;29(12):2553-2556. doi: 10.3201/eid2912.230192. Epub 2023 Nov 2.
8
The episodic resurgence of highly pathogenic avian influenza H5 virus.高致病性禽流感 H5 病毒的间歇性再现。
Nature. 2023 Oct;622(7984):810-817. doi: 10.1038/s41586-023-06631-2. Epub 2023 Oct 18.
9
Mass mortality event in South American sea lions () correlated to highly pathogenic avian influenza (HPAI) H5N1 outbreak in Chile.南美海狮()大规模死亡事件与智利高致病性禽流感(HPAI)H5N1 疫情相关。
Vet Q. 2023 Dec;43(1):1-10. doi: 10.1080/01652176.2023.2265173. Epub 2023 Oct 19.
10
Characterization of A/H7 influenza virus global antigenic diversity and key determinants in the hemagglutinin globular head mediating A/H7N9 antigenic evolution.A/H7 流感病毒全球抗原多样性的特征及其在血凝素球形头部介导 A/H7N9 抗原进化中的关键决定因素。
mBio. 2023 Oct 31;14(5):e0048823. doi: 10.1128/mbio.00488-23. Epub 2023 Aug 11.

甲型流感病毒A(H5)抗原空间中的一种疫苗抗原可提供亚型广泛的免疫力。

A vaccine antigen central in influenza A(H5) virus antigenic space confers subtype-wide immunity.

作者信息

Kok Adinda, Wilks Samuel H, Tureli Sina, James Sarah L, Bestebroer Theo M, Burke David F, Funk Mathis, van der Vliet Stefan, Spronken Monique I, Rijnink Willemijn F, Pattinson David, de Meulder Dennis, Rosu Miruna E, Lexmond Pascal, van den Brand Judith M A, Herfst Sander, Smith Derek J, Fouchier Ron A M, Richard Mathilde

机构信息

Department of Viroscience, Erasmus University Medical Center; Rotterdam, The Netherlands.

Center for Pathogen Evolution, University of Cambridge; Cambridge, United Kingdom.

出版信息

bioRxiv. 2024 Aug 6:2024.08.06.606696. doi: 10.1101/2024.08.06.606696.

DOI:10.1101/2024.08.06.606696
PMID:39553979
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11566024/
Abstract

Highly pathogenic avian influenza A(H5) viruses globally impact wild and domestic birds, and mammals, including humans, underscoring their pandemic potential. The antigenic evolution of the A(H5) hemagglutinin (HA) poses challenges for pandemic preparedness and vaccine design. Here, the global antigenic evolution of the A(H5) HA was captured in a high-resolution antigenic map. The map was used to engineer immunogenic and antigenically central vaccine HA antigens, eliciting antibody responses that broadly cover the A(H5) antigenic space. In ferrets, a central antigen protected as well as homologous vaccines against heterologous infection with two antigenically distinct viruses. This work showcases the rational design of subtype-wide influenza A(H5) pre-pandemic vaccines and demonstrates the value of antigenic maps for the evaluation of vaccine-induced immune responses through antibody profiles.

摘要

高致病性甲型H5禽流感病毒在全球范围内对野生和家养禽类以及包括人类在内的哺乳动物产生影响,凸显了其大流行潜力。甲型H5血凝素(HA)的抗原进化给大流行防范和疫苗设计带来了挑战。在此,甲型H5 HA的全球抗原进化情况在一张高分辨率抗原图谱中得以呈现。该图谱被用于设计具有免疫原性且位于抗原中心的疫苗HA抗原,引发的抗体反应能广泛覆盖甲型H5抗原空间。在雪貂身上,一种位于抗原中心的抗原对两种抗原性不同的病毒的异源感染提供了与同源疫苗相同的保护。这项工作展示了甲型H5大流行前疫苗的全亚型合理设计,并证明了抗原图谱通过抗体谱评估疫苗诱导免疫反应的价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9aac/11566024/ad6e6cc8d879/nihpp-2024.08.06.606696v1-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9aac/11566024/9a9e5d851108/nihpp-2024.08.06.606696v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9aac/11566024/cb1a5d9632d7/nihpp-2024.08.06.606696v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9aac/11566024/19f5d4c429d9/nihpp-2024.08.06.606696v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9aac/11566024/b0bc2dda96df/nihpp-2024.08.06.606696v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9aac/11566024/ad6e6cc8d879/nihpp-2024.08.06.606696v1-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9aac/11566024/9a9e5d851108/nihpp-2024.08.06.606696v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9aac/11566024/cb1a5d9632d7/nihpp-2024.08.06.606696v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9aac/11566024/19f5d4c429d9/nihpp-2024.08.06.606696v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9aac/11566024/b0bc2dda96df/nihpp-2024.08.06.606696v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9aac/11566024/ad6e6cc8d879/nihpp-2024.08.06.606696v1-f0005.jpg